Clinical trial
SEND Trial The Role of Selective Neck Dissection Used Electively in Patients With Early Oral Squamous Cell Carcinoma (1-3cm Primary Size) and No Clinical Evidence of Lymph Node Metastases in the Neck
NCT00571883 is registered in ClinicalTrials.gov with The Facial Surgery Research Foundation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- SEND Trial The Role of Selective Neck Dissection Used Electively in Patients With Early Oral Squamous Cell Carcinoma (1-3cm Primary Size) and No Clinical Evidence of Lymph Node Metastases in the Neck
- Lead sponsor
- The Facial Surgery Research Foundation
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- January 31, 2007
- Completion date
- Not reported
- Enrollment
- 652 (estimated)
- Sites
- 27
Conditions
As the registry lists them; a condition with its own page is linked.
head and neck cancer